Edward Benz
Direktor/Vorstandsmitglied bei RENOVACOR, INC.
Vermögen: - $ am 30.04.2024
Profil
Edward J.
Benz currently works at The Mount Desert Island Biological Laboratory, as Vice Chairman, F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH, as Director, The Rockefeller University, as Director, Mount Desert Island Hospital, Inc., as Director, Massachusetts Life Sciences Center, as Director from 2011, Candel Therapeutics, Inc., as Independent Director from 2017, F-star Biotechnology Ltd., as Director from 2020, Knowledge to Practice, Inc., as Director from 2015, Deciphera Pharmaceuticals, Inc., as Independent Director from 2019, Renovacor Holdings, Inc., as Director from 2017, Renovacor, Inc., as Independent Director from 2017, Riverside Partners LLC, as Advisor, and Dana-Farber, as Trustee.
Dr. Benz also formerly worked at Dana-Farber Cancer Institute, Inc., as President, Chief Executive Officer & Director from 2000 to 2016, Partners Cancercare, as Chief Executive Officer, The Johns Hopkins University School of Medicine, as Chairman-Medicine Department & Professor from 1995 to 2000, Dana-Farber, as Director from 2000 to 2016, F-Star Therapeutics, Inc. (United States), as Director, Xenetic Biosciences, Inc., as Director from 2016 to 2017, F-star Therapeutics, Inc., as Independent Director from 2019 to 2023, American Society of Hematology, as President, American Society for Clinical Investigation, as President, Harvard Medical School, as Dean in 2000, Association of American Cancer Institutes, as President, New England Journal of Medicine, as Associate Editor, Friends of The National Institute of Nursing Research, as President, and American Clinical & Climatological Association, as President.
Dr. Benz received his graduate degree from Yale University, undergraduate degree in 1968 from Princeton University, and doctorate degree from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Edward Benz
| Unternehmen | Position | Beginn |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.09.2017 |
| DECIPHERA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2019 |
| RENOVACOR, INC. | Direktor/Vorstandsmitglied | 01.07.2017 |
Mount Desert Island Hospital, Inc.
 Mount Desert Island Hospital, Inc. Hospital/Nursing ManagementHealth Services Mount Desert Island Hospital, Inc. provides healthcare services. Its services include anesthesiology, cardiology, dentistry, gastroenterology, gynecology, neurology, obstetrics, oncology, pediatrics and podiatry services. The company was founded in 1897 and is headquartered in Bar Harbor, ME. | Direktor/Vorstandsmitglied | - |
Riverside Partners LLC
 Riverside Partners LLC Investment ManagersFinance Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts. | Berater | - |
| Dana-Farber/Boston Children'S Cancer & Blood Disorders Center | Direktor/Vorstandsmitglied | - |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | - |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 09.01.2020 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.07.2017 |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Edward Benz
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Edward Benz
| Yale University | Graduate Degree |
| Princeton University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 22 |
|---|---|
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Massachusetts Life Sciences Center
 Massachusetts Life Sciences Center Investment ManagersFinance Massachusetts Life Sciences Center functions as a pension/retirement fund. The private company is based in Waltham, MA. The CEO of the company is Kenn Turner. | Finance |
Knowledge to Practice, Inc.
 Knowledge to Practice, Inc. Miscellaneous Commercial ServicesCommercial Services Knowledge to Practice, Inc. provides clinical education services. It specializes in deploy learning techniques using digital technology to help clinical leaders design and deliver a personalized curriculum that measurably improves clinical judgment, critical thinking, and patient care. The firm delivers personalized, adaptive lifelong learning solutions. Its proprietary learning platform delivers personalized, mastery-based education and point of care tools both synchronous and asynchronous with care. The company was founded by Mary Ellen Beliveau and is headquartered in Bethesda, MD. | Commercial Services |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
Association of American Cancer Institutes
 Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Commercial Services |
American Society for Clinical Investigation
 American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
| Friends of The National Institute of Nursing Research | |
The Mount Desert Island Biological Laboratory
 The Mount Desert Island Biological Laboratory BiotechnologyHealth Technology The Mount Desert Island Biological Laboratory is a non profit biomedical research institution. It helps to improve human health and well-being through basic research, education, and development ventures. The company was founded in 1898 and is headquartered in Bar Harbor, ME. | Health Technology |
| Deciphera Pharmaceuticals, Inc. | |
Dana-Farber/Harvard Cancer Center
 Dana-Farber/Harvard Cancer Center Hospital/Nursing ManagementHealth Services Dana-Farber/Harvard Cancer Center engages in the medical research and treatment services. The company is headquartered in Boston, MA. | Health Services |
| Partners Cancercare | |
Mount Desert Island Hospital, Inc.
Mount Desert Island Hospital, Inc. Hospital/Nursing ManagementHealth Services Mount Desert Island Hospital, Inc. provides healthcare services. Its services include anesthesiology, cardiology, dentistry, gastroenterology, gynecology, neurology, obstetrics, oncology, pediatrics and podiatry services. The company was founded in 1897 and is headquartered in Bar Harbor, ME. | Health Services |
| American Clinical & Climatological Association | |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology F-Star Therapeutics, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA. | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Dana-Farber/Boston Children'S Cancer & Blood Disorders Center | |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Riverside Partners LLC
Riverside Partners LLC Investment ManagersFinance Riverside Partners LLC (Riverside Partners) is a private equity firm founded in 1989. The firm is headquartered in Boston, Massachusetts. | Finance |
New England Journal of Medicine
 New England Journal of Medicine Packaged SoftwareTechnology Services The New England Journal of Medicine develops medical software. | Technology Services |
